Mesoblast (MESO) Revenue (QoQ) (2014 - 2023)
Mesoblast (MESO) Revenue (QoQ) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -4.33% |
| Mar 31, 2023 | -9.14% |
| Dec 31, 2022 | -3.83% |
| Sep 30, 2022 | -0.22% |
| Jun 30, 2022 | 10.59% |
| Mar 31, 2022 | -43.13% |
| Dec 31, 2021 | 46.00% |
| Sep 30, 2021 | -25.98% |
| Jun 30, 2021 | 67.11% |
| Mar 31, 2021 | -12.63% |
| Dec 31, 2020 | 71.72% |
| Sep 30, 2020 | -95.09% |
| Jun 30, 2020 | 1,177.13% |
| Mar 31, 2020 | 5.69% |
| Dec 31, 2019 | 5.18% |
| Sep 30, 2019 | -4.83% |
| Jun 30, 2019 | 88.77% |
| Mar 31, 2019 | -14.38% |
| Dec 31, 2018 | 11.14% |
| Sep 30, 2018 | -35.59% |